University Of California San Francisco
Man achieves long-term HIV remission without bone marrow transplant
Lessons from HIV, Ebola can help mitigate COVID-19 stigma
Hooked on ID with Harry Lampiris, MD

As a second-year medical student, I was fascinated by microbiology and pharmacology. In my third year of medical school, it became clear to me that I wanted to work in a field that required the use of broad clinical skills (both inpatient and outpatient) and that focused on the complex relationship between patients and their environment. During residency, I always found the ID cases most compelling and interesting, and I was frequently awestruck by the clinical acumen of ID physicians. But, mostly, it was the concept of the “magic bullet,” first described by Paul Ehrlich, the Nobel Prize-winning father of antimicrobial chemotherapy, that spoke directly to me. The clinical impact of antimicrobial therapy “snatching patients from the jaws of death,” which I frequently observed as a resident physician, made it clear to me that I wanted to be intimately involved in this seemingly miraculous process.
Ophthalmic societies protest use of rubber bullets, tear gas on citizens
Novel tremelimumab-durvalumab regimen safe, effective in advanced liver cancer
‘We should have been prepared’: COVID-19 devastates vulnerable US

A little more than 3 years before the United States announced its first confirmed case of what would come to be called COVID-19, Anthony S. Fauci, MD, told a gathering of students and global health experts at Georgetown University there was “no doubt” that the Trump administration would face a surprise infectious disease outbreak. Fauci’s experience as director of the National Institute of Allergy and Infectious Diseases for more than 30 years told him that it was inevitable. Since 2000 alone, there had been outbreaks of West Nile virus, severe acute respiratory syndrome (SARS) and Zika virus, the 2009 H1N1 influenza pandemic and the years-long West African Ebola epidemic.